In this study, we aimed to determine the feasibility of using a lymphodepleted NHP model for the assessment of acute on‐target/off‐tumor toxicity after a single infusion of human peripheral blood mononuclear cell‐(PBMC)‐derived, EPHB4‐specific CAR‐T cells. This evidence concerns the gene EPHB4 and neoplasm.